» Articles » PMID: 19336757

Regulatory T-cell Status in Red Cell Alloimmunized Responder and Nonresponder Mice

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2009 Apr 2
PMID 19336757
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Red blood cell alloimmunization remains a major complication for transfusion-dependent patients, but immune factors governing risk for alloimmunization are unknown. We hypothesized that CD4+ regulatory T cells (Tregs), which we have shown control the rate and the frequency of red blood cell alloimmunization in mouse models, may dictate responder/nonresponder status. Using a transfusion regimen in which more than 50% of mice develop alloantibodies to human glycophorin A antigen, we found reduced in vitro and in vivo Treg-suppressive activity in responders compared with nonresponders that was the result of impaired Treg suppressor function. Moreover, responders were prone to developing additional alloantibodies to strong immunogens, whereas nonresponders were resistant to alloimmunization. Altogether, our data raise the possibility that Treg activity may be used as a marker for identifying responder/nonresponder status in transfusion recipients.

Citing Articles

IFN-I promotes T-cell-independent immunity and RBC autoantibodies via modulation of B-1 cell subsets in murine SCD.

Su S, Bao W, Liu Y, Shi P, Manwani D, Murakhovskaya I Blood. 2024; 145(3):334-347.

PMID: 39656114 PMC: 11775509. DOI: 10.1182/blood.2024025175.


Could the Crosstalk Between Myeloid-Derived-Suppressor Cells and Regulatory T Cells Have a Role in Beta-Thalassemia?.

Zahran A, El-Badawy O, Badawy E, Elsayh K, Gad E, Saad K J Hematol. 2023; 12(4):161-169.

PMID: 37692868 PMC: 10482610. DOI: 10.14740/jh1149.


The Development and Consequences of Red Blood Cell Alloimmunization.

Arthur C, Stowell S Annu Rev Pathol. 2022; 18:537-564.

PMID: 36351365 PMC: 10414795. DOI: 10.1146/annurev-pathol-042320-110411.


Red blood cell alloimmunization and sickle cell disease: a narrative review on antibody induction.

Hendrickson J Ann Blood. 2021; 5.

PMID: 33554044 PMC: 7861514. DOI: 10.21037/aob-2020-scd-01.


Type 1 Interferon Gene Signature Promotes RBC Alloimmunization in a Lupus Mouse Model.

Lee J, Madany E, El Kadi N, Pandya S, Ng K, Yamashita M Front Immunol. 2020; 11:584254.

PMID: 33101313 PMC: 7546415. DOI: 10.3389/fimmu.2020.584254.


References
1.
Vichinsky E, Luban N, Wright E, Olivieri N, Driscoll C, Pegelow C . Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion. 2001; 41(9):1086-92. DOI: 10.1046/j.1537-2995.2001.41091086.x. View

2.
Thornton A, Shevach E . CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998; 188(2):287-96. PMC: 2212461. DOI: 10.1084/jem.188.2.287. View

3.
Krieg A . CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002; 20:709-60. DOI: 10.1146/annurev.immunol.20.100301.064842. View

4.
Chaudhuri A, Yuen G, Fang F, Storry J . Development of Duffy transgenic mouse: in vivo expression of human Duffy gene with -33T-->C promoter mutation in non-erythroid tissues. Br J Haematol. 2004; 127(3):356-9. DOI: 10.1111/j.1365-2141.2004.05208.x. View

5.
Zimring J, Hendrickson J . The role of inflammation in alloimmunization to antigens on transfused red blood cells. Curr Opin Hematol. 2008; 15(6):631-5. DOI: 10.1097/MOH.0b013e328313695e. View